Health Care
Labcorp grew revenue 5.8% year-over-year in Q2 FY2026 with expanding margins across both segments, but its cash position weakened significantly amid higher acquisition spending and share buybacks.
Key risk: Liquidity Risk
Cash and cash equivalents fell to $141.8 million, down 78.1% year-over-year, primarily due to acquisitions and share repurchases. This low cash balance, combined with upcoming debt maturities, could pose liquidity challenges if operating cash flows weaken.
Other Health Care Services companies